This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.16.0: STU 2 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-request-doxorubicin-jenny-m"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><p><b>Treatment Intent</b>: <span title="Codes: {http://snomed.info/sct 373808002}">Curative - procedure intent (qualifier value)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>category</b>: <span title="Codes: {http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}">Outpatient</span></p><p><b>medication</b>: <span title="Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 3639}">DOXOrubicin</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-jenny-m.html">Generated Summary: Medical Record Number: MRN1234 (USUAL); Jenny M ; gender: female; birthDate: 1965-01-01</a></p><p><b>authoredOn</b>: 2018-04-12</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-owen-oncologist.html">Generated Summary: id: 9988776655; Owen Oncologist ; gender: male</a></p><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-jenny-m.html">Generated Summary: <span title="Codes: {http://terminology.hl7.org/CodeSystem/condition-clinical remission}">Remission</span>; <span title="Codes: {http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}">Confirmed</span>; <span title="Codes: {http://terminology.hl7.org/CodeSystem/condition-category problem-list-item}">Problem List Item</span>; <span title="Codes: {http://snomed.info/sct 353431000119107}">Primary malignant neoplasm of female left breast (disorder)</span>; onset: 2018-03-16</a></p><h3>DosageInstructions</h3><table class="grid"><tr><td>-</td></tr><tr><td>*</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-treatment-intent">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="373808002"/>
<display value="Curative - procedure intent (qualifier value)"/>
</coding>
</valueCodeableConcept>
</extension>
<status value="active"/>
<intent value="order"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/medicationrequest-category"/>
<code value="outpatient"/>
</coding>
</category>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="3639"/>
<display value="DOXOrubicin"/>
</coding>
</medicationCodeableConcept>
<subject>
<reference value="Patient/cancer-patient-jenny-m"/>
</subject>
<authoredOn value="2018-04-12"/>
<requester>
<reference value="Practitioner/us-core-practitioner-owen-oncologist"/>
</requester>
<reasonReference>
<reference value="Condition/primary-cancer-condition-jenny-m"/>
</reasonReference>
<dosageInstruction>
<text value="doxorubicin (60 mg/m² IV)"/>
<timing>
<repeat>
<boundsPeriod>
<start value="2018-04-01"/>
</boundsPeriod>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous route (qualifier value)"/>
</coding>
</route>
<doseAndRate>
<rateQuantity>
<value value="60"/>
<unit value="mg/m2"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/m2"/>
</rateQuantity>
</doseAndRate>
<maxDosePerPeriod>
<numerator>
<value value="1"/>
</numerator>
<denominator>
<value value="3"/>
<unit value="week"/>
<system value="http://unitsofmeasure.org"/>
<code value="wk"/>
</denominator>
</maxDosePerPeriod>
</dosageInstruction>
</MedicationRequest>